Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bellus Health Inc
(NQ:
BLU
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bellus Health Inc
< Previous
1
2
3
4
Next >
36 Stocks Moving In Tuesday's Mid-Day Session
September 14, 2021
Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August
September 14, 2021
Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With BELLUS Health's Stock Today?
September 13, 2021
BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough....
Via
Benzinga
Understanding BELLUS Health's Unusual Options Activity
August 12, 2021
On Thursday, shares of BELLUS Health (NASDAQ:BLU) saw unus...
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
BELLUS Health Stock Shines After Refractory Chronic Cough Trial Data
September 13, 2021
BELLUS Health Inc (NASDAQ: BLU) has announced a positive interim analysis from Phase 2b SOOTHE trial of BLU-5937 for refractory chronic cough (RCC). BLU-5937, the...
Via
Benzinga
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
September 13, 2021
From
BELLUS Health Inc.
Via
Business Wire
72 Biggest Movers From Yesterday
September 14, 2021
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...
Via
Benzinga
BELLUS Health to Present at the H.C. Wainwright Global Investment Conference
September 02, 2021
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health to Report Additional RELIEF Data in an Oral Presentation at the European Respiratory Society International Congress 2021
August 23, 2021
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Reports Second Quarter 2021 Financial Results and Business Highlights
August 11, 2021
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Inc. (NASDAQ:BLU) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
July 01, 2021
San Diego, CA -- (SBWIRE) -- 07/01/2021 -- Certain directors of BELLUS Health Inc are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference
May 25, 2021
From
BELLUS Health Inc.
Via
Business Wire
BELLUS Health Inc. (NASDAQ:BLU) Investor Notice: Deadline in Lawsuit on May 17, 2021
May 17, 2021
San Diego, CA -- (SBWIRE) -- 05/17/2021 -- A deadline is coming up on May 17, 2021 in the lawsuit filed for certain investors of BELLUS Health Inc. (NASDAQ:BLU).
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
DEADLINE TODAY: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BLU FINAL DEADLINE ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages BELLUS Health Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – BLU
May 15, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.
May 15, 2021
NEW YORK, NY / ACCESSWIRE / May 15, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class...
From
Bernstein Liebhard LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 14, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Bellus Health, Inc. and Encourages Investors to Contact the Firm
May 13, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BELLUS Health Inc. (BLU)
May 13, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 13, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 12, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
May 12, 2021
From
BELLUS Health Inc.
Via
Business Wire
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 11, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
May 10, 2021
From
BELLUS Health Inc.
Via
Business Wire
7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 10, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BELLUS Health to Present at the American Thoracic Society 2021 International Conference
May 10, 2021
From
BELLUS Health Inc.
Via
Business Wire
BLU CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff in a Securities Class Action Lawsuit Against BELLUS Health, Inc.
April 29, 2021
NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class...
From
Bernstein Liebhard LLP
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
BLU Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021
April 28, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
BLU Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies BELLUS Health Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
April 13, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.